World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
59
Citations
11111
World Ranking
2027
National Ranking
48

Liang Qiao publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Liang Qiao sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 198 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Liang Qiao D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Liang Qiao sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 59 D-Index — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Liang Qiao is a researcher affiliated with the University of Sydney in Australia, specializing in medicine with extensive work in biochemistry, genetics, and molecular biology. Their published research spans 94 publications in medicine and 71 publications in related molecular life sciences.

Their key subfields of study include molecular biology, cancer research, oncology, hepatology, and epidemiology. Liang Qiao's research covers several main topics such as microRNA in disease regulation, liver disease diagnosis and treatment, cancer-related molecular mechanisms research, circular RNAs in diseases, climate variability and models, cancer mechanisms and therapy, and hepatocellular carcinoma treatment and prognosis.

Frequently publishing in venues like Cancer Letters, bioRxiv (Cold Spring Harbor Laboratory), and Scientific Reports, Liang Qiao has contributed notably to the scientific literature. They have also published books, including one titled Insights in Gastrointestinal Cancers: 2021 through Frontiers Media.

Some recent papers authored or coauthored by Liang Qiao include:

  • A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer, 2020, Molecular Cancer
  • Soil moisture-atmosphere coupling accelerates global warming, 2023, Nature Communications
  • Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications, 2024, Cancer Gene Therapy
  • The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells, 2021, Scientific Reports
  • Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy, 2024, Nature Cancer

Liang Qiao collaborates frequently with a group of coauthors, including Jacob George, Romario Nguyen, Zhiyan Zuo, Sarah Da Won Bae, and Kaiwen Zhang, reflecting ongoing partnerships in the fields of cancer and molecular biology.

Their work notably combines clinical and molecular perspectives to address challenges in cancer research, liver diseases, and environmental factors influencing global health. Liang Qiao's research outputs contribute to understanding the molecular mechanisms behind disease progression and treatment responses.

Best Publications

  • Helicobacter pylori-induced gastric inflammation and gastric cancer

    Fei Wang;Wenbo Meng;Bingyuan Wang;Liang Qiao

  • Pathogenesis of liver cirrhosis.

    Wen-Ce Zhou;Quan-Bao Zhang;Liang Qiao

  • Deoxycholic Acid (DCA) Causes Ligand-independent Activation of Epidermal Growth Factor Receptor (EGFR) and FAS Receptor in Primary Hepatocytes: Inhibition of EGFR/Mitogen-activated Protein Kinase-Signaling Module Enhances DCA-induced Apoptosis

    Liang Qiao;Elaine Studer;Kevin Leach;Robert McKinstry

  • Cancer stem cells: A contentious hypothesis now moving forward.

    Michael L. O’Connor;Dongxi Xiang;Sarah Shigdar;Joanna Macdonald

  • Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival.

    Steven Grant;Liang Qiao;Paul Dent

  • Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats

    Zheng-Jie Xu;Jian-Gao Fan;Xiao-Dong Ding;Liang Qiao

  • Bile Acid Regulation of C/EBPβ, CREB, and c-Jun Function, via the Extracellular Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase Pathways, Modulates the Apoptotic Response of Hepatocytes

    Liang Qiao;Song Iy Han;Youwen Fang;Jong Sung Park

  • tRF/miR-1280 Suppresses Stem Cell-like Cells and Metastasis in Colorectal Cancer.

    Bingqing Huang;Bingqing Huang;Huipeng Yang;Xixi Cheng;Dan Wang

  • RNA aptamers targeting cancer stem cell marker CD133

    Sarah Shigdar;Liang Qiao;Shu-Feng Zhou;Dongxi Xiang

  • Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes

    Liang Qiao;Adly Yacoub;Elaine Studer;Seema Gupta

  • Role of Notch signaling in colorectal cancer

    Liang Qiao;Benjamin C Y Wong

  • A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer.

    Zihao Pan;Jianye Cai;Jiatong Lin;Huinian Zhou

  • Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways.

    Jong-Sung Park;Liang Qiao;Zao-Zong Su;Darin Hinman

  • Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo

    Jun Yu;Liang Qiao;Lars Zimmermann;Matthias P. A. Ebert

  • Targeting apoptosis as an approach for gastrointestinal cancer therapy.

    Liang Qiao;Benjamin C.Y. Wong

  • Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively

    Biao Huang;Xixi Cheng;Huafeng Wang;Huafeng Wang;Wenjing Huang

  • Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival

    Yong-Ning Zhou;Cai-Pu Xu;Biao Han;Min Li

  • Hepatitis B virus-induced hepatocellular carcinoma

    Cheng Xu;Wence Zhou;Yuming Wang;Liang Qiao

  • LECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis.

    Meng Xu;Hong-Hai Xu;Yuan Lin;Xiangnan Sun

  • Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells.

    Xiaoqi Huo;Shuanglin Han;Shuanglin Han;Guang Wu;Olivier Latchoumanin

Frequent Co-Authors

Jacob George
Jacob George University of Sydney
Benjamin C.Y. Wong
Benjamin C.Y. Wong University of Hong Kong
Paul Dent
Paul Dent Virginia Commonwealth University
Steven Grant
Steven Grant Virginia Commonwealth University
George D. Wilson
George D. Wilson Beaumont Health
Adly Yacoub
Adly Yacoub Virginia Commonwealth University
Christopher Liddle
Christopher Liddle University of Sydney
Paul B. Fisher
Paul B. Fisher Virginia Commonwealth University
Hui Y. Lan
Hui Y. Lan Chinese University of Hong Kong
Geoffrey C. Farrell
Geoffrey C. Farrell Australian National University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology opens doors to many career options in health and science. For those interested in clinical communication, asha accredited slp programs are available online. These programs lead to rewarding roles as Speech-Language Pathologists, a field that values scientific understanding and patient care.

Students from a non-SLP background may want to pursue speech pathology bridge programs. These flexible pathways enable you to shift your focus to speech pathology, building on your molecular biology knowledge while meeting licensing prerequisites.

If your interests lean toward nursing, accelerated bsn programs for non nurses offer a quick and cost-effective entry into nursing careers without prior clinical training. This can complement a science background and broaden your career prospects.

For advanced roles, consider psychiatric nursing, which often requires specialized qualifications but comes with strong job outlooks. Explore typical psychiatric nurse practitioner salary information by state to assess your long-term earning potential.

Best Scientists Citing Liang Qiao

Trending Scientists

Recently Published Articles